- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05834036
Effect of Antibiotics on Enteric Neurons and Glia
Effect of Antibiotics on Submucosal Enteric Neurons and Glia in the Lower Gastrointestinal
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The enteric nervous system (ENS) has been recognized as the "second brain" as it can regulate enteric physiology without central nervous system input. Similar to the central nervous system, it is composed of multiple neuron populations whose main functions are gut motility, secretion, and absorption. In addition to the neurons, the ENS contains glia cells whose main role is neuroprotection but also contribute to normal gut motility. Several studies have demonstrated that the microbiota and the ENS have an intimate relationship that begins in utero, and it is critical for its normal development. Neurons can recognize bacteria and their products. Several investigators have shown neuronal loss after enteric infections and antibiotic (Ampicillin) treatment in the muscularis layer, that results in delayed transit time in animal models. Hence, communication between the microbiota and the ENS is important to maintain normal gut motility. Disorders of Gut-Brain Interactions (DGBIs) are quite common, among these are Irritable Bowel Syndrome (IBS) defined by Rome IV criteria as abdominal pain associated with a change in consistency and frequency of bowel movements and the constipation predominant subtype (less than 3 bowel movements per week) is the most prevalent, which is also the most common motility disorder that mouse models of infection and antibiotics treatment exhibit. IBS has been associated with dysbiosis and a recent study demonstrated that antibiotic use immediately before or after screening colonoscopy increased the risk of developing IBS. In addition, dysfunction of submucosal neurons in IBS has been previously reported but whether there are changes in neuron numbers or neuron characteristics has not been explored. While there have been prospective studies that have explored the effects of antibiotics in patients treated for Helicobacter Pylori, there have been other investigators who have focused on the long term effects of antibiotics in healthy volunteers.
Therefore, similar to animal models, investigators propose that humans experience a profound and transient loss/alteration of neurons in the setting of antimicrobial use associated dysbiosis that manifest as DGBIs, most notably the constipation subtypes. This proposal will address whether antimicrobial use leads to quantitative and qualitative changes in the populations of submucosal neurons and glia cells in human subjects.
This hypothesis will be tested in a prospective study in which healthy participants will be asked to take the commonly used antibiotic amoxicillin twice a day for 7 days, and colon tissue biopsies will be obtained before and after treatment. Human tissue will be processed and analyzed to visualize structural changes, and changes in gene expression, bacteria, metabolites will be determined through single nuclei RNA sequencing, 16S ribosomal bacteria RNA sequencing and metabolomics analysis respectively.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Recruitment Office
- Phone Number: 1-800-782-2737
- Email: RUcares@Rockefeller.edu
Study Contact Backup
- Name: Yelina Alvarez, MD/PhD
- Phone Number: 2123277521
- Email: yalvarez@rockefeller.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Rockefeller University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-75 years old of different sex and races.
Exclusion Criteria:
- Allergy to penicillin, amoxicillin, augmentin, ampicillin, and other antibiotics in the penicillin family
- Pregnancy or fertility treatments
- Usage of antibiotics, antifungals or antivirals within three months prior to participation
- Change in dietary habits within the last three months prior to participation such as transitioning from high fat western diet to primarily plant based diet, initiation of ketogenic, paleo or any other weight loss regimen.
- Acute (in the past 30 days) or chronic enteric infections, including C. difficile.
- Chronic gastrointestinal disorder including inflammatory bowel disease, celiac disease , irritable bowel syndrome, chronic constipation or diarrhea
- Active neuropsychiatric disorder that requires anti-psychotic ie typical and atypical antipsychotics as well as anti-epileptics, levodopa, rivastigmine or any other neuropsychiatric medication with dopaminergic and cholinergic effects.
- Myocardial infarction or cerebrovascular accident in the six months prior to participation
- Coagulation disorders
- Chronic immunosuppressive medication (systemic) usage
- Anti-coagulation and anti-platelet agents such as plavix, warfarin, heparin, direct oral anticoagulants.
- Low dose Aspirin does not constitute an exclusion criteria.
- Prior episode of C. difficile infection.
- Prosthetic heart valves or any other conditions that require pre-procedure antibiotics.
- Currently receiving chemotherapy
- Any medical, psychological or social condition, in the opinion of the investigator, would jeopardize the health or well-being of the participant, interfere with their participation in the study, or confound the results of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy Controls
|
Amoxicillin 875mg every 12 hours for 7 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of colonic submucosal neurons in the colon
Time Frame: 1 year
|
Total number of colonic submucosal neurons counted per mm^2 before and after antibiotics treatment.
|
1 year
|
Number of colonic submucosal glia in the colon
Time Frame: 1 year
|
Total number of colonic submucosal glia counted per mm^2 before and after antibiotics treatment.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in gene expression in submucosal neurons
Time Frame: 1 year
|
Neurons nuclei will be isolated, and RNA will be sequenced and identified through alignment to human genome.
The amount of RNA will be normalized as transcripts per million (TPM unit) and fold changes of a transcript will be calculated by dividing the TPM numbers of a transcript before and after antibiotics treatment.
|
1 year
|
Changes in gene expression in submucosal glia
Time Frame: 1 year
|
Glia nuclei will be isolated, and RNA will be sequenced and identified through alignment to human genome.
The amount of RNA will be normalized as transcripts per million (TPM unit) and fold changes of a transcript will be calculated by dividing the TPM numbers of a transcript before and after antibiotics treatment.
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yelina Alvarez, MD/PhD, Rockefeller University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- YAL-1038
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antibiotic Enterocolitis
-
Genzyme, a Sanofi CompanyCompletedClostridium Difficile-Associated Diarrhea | Antibiotic-associated Diarrhea | Clostridium Enterocolitis | Clostridium Difficile Diarrhea | Antibiotic-associated ColitisUnited States, Canada, United Kingdom, Puerto Rico
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineWithdrawnEnterocolitis | Pseudomembranous Colitis | Antibiotic-associated ColitisUnited States
-
McMaster UniversityThe Physicians' Services Incorporated FoundationCompletedAntibiotic-Associated Diarrhea | Clostridium Enterocolitis | Pseudomembranous Colitis | Pseudomembranous Enterocolitis | Pseudomembranous EnteritisCanada
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineCompletedClostridium Enterocolitis | Pseudomembranous Colitis | Antibiotic-Associated ColitisUnited States
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineCompletedClostridium Enterocolitis | Pseudomembranous Colitis | Antibiotic-Associated ColitisUnited States
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineCompletedClostridium Enterocolitis | Pseudomembranous Colitis | Antibiotic-Associated ColitisUnited States
-
University of PennsylvaniaNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingDysbiosis | Clostridium Difficile | Antibiotic-Associated Colitis | Pet-Human BondingUnited States
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineCompletedEnterocolitis | Pseudomembranous Colitis | Antibiotic-Associated ColitisUnited States
-
Pharmbio Korea Co., Ltd.CompletedPulmonary Infection | Antibiotics Associated ColitisKorea, Republic of
-
Genzyme, a Sanofi CompanyCompletedAntibiotic-Associated Diarrhea | Pseudomembranous Colitis | Clostridium Difficile DiarrheaCanada
Clinical Trials on Amoxicillin Oral Capsule
-
St. Louis UniversityCompletedInflammation at Mini-screw Insertion Site | Mobility, Mini-screwUnited States
-
Nucleo De Pesquisa E Desenvolvimento De Medicamentos...University of Campinas, BrazilCompletedBariatric Surgery CandidateBrazil
-
Brigham and Women's HospitalCompleted
-
China Academy of Chinese Medical SciencesBeijing Chao Yang Hospital; The First Affiliated Hospital of Henan University... and other collaboratorsUnknownAcute Tonsillitis
-
Aelis FarmaNational Institute on Drug Abuse (NIDA)CompletedHealthy VolunteersUnited States
-
Saskatchewan Health Authority - Regina AreaNot yet recruiting
-
Brigham and Women's HospitalEnrolling by invitation
-
EicOsis Human Health Inc.National Institute of Neurological Disorders and Stroke (NINDS)CompletedHealthy AdultsUnited States
-
Brigham and Women's HospitalCompleted
-
Yale UniversityNeurocrine BiosciencesRecruitingTrichotillomania (Hair-Pulling Disorder)United States